Losartan Potassium Tablet, Film Coated
Product Images NDC 68071-2203

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68071-2203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2203 9)

This is a label of Losartan Potassium 100mg tablets produced by NuCare Pharmaceuticals, Inc. It contains information about product details such as the NDC number, lot number, and expiration date. It warns to keep out of reach of children and store at controlled temperature. Customers are advised to check the manufacturer's label for a full list of ingredients.*

FDA Label Image

Image002 (Image 01)

This text provides data from a study comparing the effectiveness of Atenolol and Losartan Potassium in reducing the risk of a primary endpoint in patients. The adjusted risk reduction of Losartan Potassium compared to Atenolol is reported as 13%, with a p-value of 0.021. The study monitored patients over a period of 66 months, with data recorded at various monthly intervals from month 6 to month 66.*

FDA Label Image

Image003 (Image 02)

This is a chart that shows the percentage of patients who experienced a fatal or non-fatal stroke over a period of 66 months. Two medications, Atenolol and Losartan potassium, are being compared. However, the chart does not provide enough information to evaluate the effectiveness of either medication.*

FDA Label Image

Image004 (Image 03)

This appears to be a table showing the results of a study related to stroke rates in patients based on age, gender, race, and medical history with Losartan Potassium and Atenolol medications. The table displays the number of events, rate percentages and hazard ratios for each medication subgroup.*

FDA Label Image

Image005 (Image 04)

This text presents statistical information about risk reduction and event occurrences in a certain population. The risk reduction is reported as 16.1% and the value of p is given as 0.022. The chart shows the percentage of patients with events in two categories, represented as 40% and 20%.*

FDA Label Image

Image001 (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.